(Q43923444)

28 November 2017

title

Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance (English)

1 reference

28 November 2017

Sivridis E

1

1 reference

28 November 2017

Giatromanolaki A

2

1 reference

28 November 2017

Koukourakis MI

3

1 reference

28 November 2017

Georgiou L

4

1 reference

28 November 2017

Anastasiadis P

5

1 reference

28 November 2017

publication date

1 January 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

40

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

92-100

1 reference

MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Is episialin/MUC1 involved in breast cancer progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

MUC1 in secretory phase endometrium: expression in precisely dated biopsies and flushings from normal and recurrent miscarriage patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Episialin acts as an antiadhesive factor in an in vitro model of human endometrial-blastocyst attachment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Lectin-binding patterns in normal, hyperplastic and neoplastic endometrium: the prognostic value of concanavalin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01316.X

10.1046/J.1365-2559.2002.01316.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference